South America Ovarian Cancer Diagnostics and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented By Cancer Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, and Others), Modality and Geography

Market Snapshot

CAGR
Study Period:

2018 - 2026

Base Year:

2020

CAGR:

9.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The rising incidences of ovarian cancer are one of the primary drivers for the market. The cancer burden is increasing, owing to factors such as the aging population, poor diet, smoking, and physical inactivity. According to Globocan, in 2018, there were around 243,588 deaths due to cancer in Brazil. Ovarian cancer (OC) is the most common cancer among women. OC has a high mortality rate and is difficult to diagnose. Due to its silent progression, it is contributing to the high mortality rate. Thus, due to the increasing incidence of ovarian cancer, the market for cancer diagnostics and therapeutics is expected to see stable growth in South America. Additionally, the rising geriatric population and increase in healthcare expenditure also contribute to the growth of the market.

Scope of the report

As per the scope of the report, Ovarian cancer is a type of cancer that begins in the ovaries. There are several types of ovarian cancer, among which Epithelial ovarian cancer is the most common type of ovarian cancer. The report covers various diagnostic and therapeutics used in the treatment of ovarian cancer.

By Cancer Type
Epithelial Ovarian Tumors
Ovarian Germ Cell Tumors
Others
By Modality
Diagnosis
Biopsy
Blood Tests
Ultrasound
PET
CT Scan
Other Diagnosis
Therapeutics
Chemotherapy
Radiation Therapy
Immunotherapy
Hormonal Therapy
Others
Geography
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

CT Scan Segment is Expected to Show Better Growth in the Forecast Years

  • Based on Diagnosis, the market is segmented into Biopsy, Blood Tests, Ultrasound, PET, CT Scan and Other Diagnosis. 
  • Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). These equipment do not show small ovarian tumors well, but they can see larger tumors and may be able to see if the tumor is growing into nearby structures. 
  • The use of modern CT machines with robot-assisted surgical systems is improving surgical outcomes. Hence, CT machines are the highly beneficial and preferred method of imaging for many conditions, which is expected to propel the growth of the market, over the forecast period. 
South America Ovarian Cancer Diagnostics and Therapeutics Market 1

To understand key trends, Download Sample Report

Competitive Landscape

The market for ovarian cancer diagnostics and therapeutics market in South America is moderately competitive and consists of the global players such as AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson and Siemens AG, Furthermore, with rising technological advancements and innovation, more companies are expected to penetrate the market in the coming future.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Ovarian Cancer

      2. 4.2.2 Rising Geriatric Population

      3. 4.2.3 Increase in Healthcare Expenditure

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Cancer Type

      1. 5.1.1 Epithelial Ovarian Tumors

      2. 5.1.2 Ovarian Germ Cell Tumors

      3. 5.1.3 Others

    2. 5.2 By Modality

      1. 5.2.1 Diagnosis

        1. 5.2.1.1 Biopsy

        2. 5.2.1.2 Blood Tests

        3. 5.2.1.3 Ultrasound

        4. 5.2.1.4 PET

        5. 5.2.1.5 CT Scan

        6. 5.2.1.6 Other Diagnosis

      2. 5.2.2 Therapeutics

        1. 5.2.2.1 Chemotherapy

        2. 5.2.2.2 Radiation Therapy

        3. 5.2.2.3 Immunotherapy

        4. 5.2.2.4 Hormonal Therapy

        5. 5.2.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 South America

        1. 5.3.1.1 Brazil

        2. 5.3.1.2 Argentina

        3. 5.3.1.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AstraZeneca plc

      2. 6.1.2 Boehringer Ingelheim GmbH

      3. 6.1.3 Bristol-Myers Squibb Company

      4. 6.1.4 Eli Lilly and Company

      5. 6.1.5 F. Hoffman-La Roche Ltd

      6. 6.1.6 GlaxoSmithKline plc

      7. 6.1.7 Johnson & Johnson

      8. 6.1.8 Siemens AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The South America Ovarian Cancer Diagnostics and Therapeutics Market market is studied from 2018 - 2026.

The South America Ovarian Cancer Diagnostics and Therapeutics Market is growing at a CAGR of 9.2% over the next 5 years.

  • AstraZeneca plc
  • F. Hoffman-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Siemens AG

Are the major companies operating in South America Ovarian Cancer Diagnostics and Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!